Publication:
Lower levels of IL-4 and IL-10 influence lipodystrophy in HIV/AIDS patients under antiretroviral therapy

dc.contributor.authorDragović, Gordana (23396934400)
dc.contributor.authorDimitrijević, Božana (59097555200)
dc.contributor.authorKhawla, Al Musalhi (57193262910)
dc.contributor.authorSoldatović, Ivan (35389846900)
dc.contributor.authorAndjić, Mladen (57725550500)
dc.contributor.authorJevtović, Djordje (55410443900)
dc.contributor.authorNair, Devaki (7005754649)
dc.date.accessioned2025-07-02T12:21:23Z
dc.date.available2025-07-02T12:21:23Z
dc.date.issued2017
dc.description.abstractBackground The role of interleukins in the pathogenesis of lipodystrophy in HIV/AIDS-patients is still not understood. The aim of this study was to evaluate the relationship between serum levels of interleukins between HIV/AIDS-patients with or without lipodystrophy, as well as between different subgroups of lipodystrophy (lipoatrophy, lipohypertrophy, mixed-fat-redistribution) and patients without lipodystrophy. Methods Cross-sectional study of 66 HIV/AIDS patients, all Caucasians. Serum levels of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10) were measured using Cytokine-Array-1 on Evidence Investigator, Biochip Array Technology. The associations between interleukins and anthropometric and metabolic variables were estimated by Spearman-correlation. Analysis of covariance with bootstrapping method (ACBM) was used to examine relationship between interleukins and lipodystrophy categories adjusted for confounding variables. Results The lipodystrophy was observed in 29 (44%) patients, while 15 (52%) had lipoatrophy, 4 (14%) lipohypertrophy and 10 (34%) patients had mixed fat redistribution. There were 37 (56%) patients without lipodystrophy. Significantly lower levels of IL-4 and IL-10 were observed in lipodystrophy vs. non-lipodystrophy (p = 0.008; p = 0.027, respectively). No differences were found relating IL-1α, IL-1β, IL-2, IL-6 and IL-8 levels in lipodystrophy vs. non-lipodystrophy. In patient subgroup with lipoatrophy, significantly lower levels of IL-4 and IL-10 were found when compared to non-lipodystrophy (p = 0.043; p = 0.031, respectively). In lipohypertrophy subgroup significantly lower levels of IL-4 were found when compared to non-lipodystrophy (p = 0.003). In order to estimate the correlation of IL-4 and IL-10 and the presence of lipodystrophy, ACBM showed that correlation of IL-4 levels in patients with lipodystrophy remains statistically significant (p = 0.004) in all types of lipodystrophy: lipoatrophy, lipohypertrophy and mix-fat-redistribution (p = 0.027; p = 0.009; p = 0.017, respectively) after adjustment for age, BMI. Conclusions IL-4 and IL-10 levels were significantly lower in lipodystrophy vs. non-lipodystrophy. According to our knowledge, we showed for the first time significant correlation between IL-4 levels and lipodystrophy development in HIV/AIDS patients. © 2017
dc.identifier.urihttps://doi.org/10.1016/j.yexmp.2017.02.001
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85012214836&doi=10.1016%2fj.yexmp.2017.02.001&partnerID=40&md5=0de503b8807ef45718651f796fdb0af3
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/13257
dc.subjectcART
dc.subjectHIV/AIDS patients
dc.subjectIL-10 levels
dc.subjectIL-4 levels
dc.subjectLipodystrophy
dc.titleLower levels of IL-4 and IL-10 influence lipodystrophy in HIV/AIDS patients under antiretroviral therapy
dspace.entity.typePublication

Files